Mohammad Shoaib

Dr. Mohammad Shoaib

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 November 2019 in Andrologia
Verified
Journal Article
Closed access
PDF file
SJSalman Jamil
Salman Jamil
Mohammad ShoaibMohammad Shoaib
Mohammad Shoaib
WAWajahat Aziz
Wajahat Aziz
MAMohammad Hammad Ather
Mohammad Hammad Ather
Nonsomatic factors play a significant role in erectile dysfunction. We assessed the impact on men suffering from male factor infertility by employing the validated Self‐Esteem and Relationship questionnaire (SEAR) and compared the scores with controls. Men with primary infertility were asked to fill SEAR questionnaire. Normal fertile men visiting clinic for unrelated problem or normal male accompanying infertile patients constitute the control group. Transformed score of each domain and total score of SEAR questionnaire and means were compared. Data were analysed by R version 5.2. Univariate and multivariate analyses were done to determine factors predicting self‐esteem and total relationship score. There were 45 men each in the study and control groups. The mean transformed self‐esteem score and total score of infertile men were significantly lower as compared to controls (74.44 versus 95.83) and (73.54 versus 95.86) p‐value of <.0001. Longer duration of infertility, advanced age, diabetes and higher education were factors significantly lowering the scores on univariate analysis, and on multivariate analysis, diabetes was the only significant predictor of total SEAR score in infertile men. Infertility leads to lower self‐esteem, sexual performance and confidence among infertile men as compared to controls. The relationship score worsens with increasing duration of infertility.

10 November 2020 in Cureus
Verified
Journal Article
Open access
PDF file
Mohammad ShoaibMohammad Shoaib
Mohammad Shoaib
MBMuhibullah Bangash
Muhibullah Bangash
BSBasit Salam
Basit Salam
MAM Hammad Ather
M Hammad Ather
In this study, we aimed to determine the correlation between the STONE score [(S)ize of the stone, (T)opography or location, degree of (O)bstruction of the urinary system, (N)umber of stones, and (E)valuation of Hounsfield units] and postoperative hemoglobin drop in patients undergoing percutaneous nephrolithotomy (PCNL). This was a prospective observational study and all adult patients aged 18-65 years undergoing unilateral, single-tract PCNL using 26 Ch. Amplatz sheath for renal calculi were included. The five variables of the STONE nephrolithometry score were calculated prior to the procedure. The stone-free rates were assessed on imaging at four weeks and complications were graded using the modified Clavien system. Of the 142 patients included, 75% were below 55 years of age. More than half of our patients were diabetic with more than 60% having a body mass index (BMI) above 25 kg/m2. The mean STONE score was 7 with 33% having a high (>9) STONE score. The mean hemoglobin drop was 1.15 +0.92 g/dL with eight patients (5.63%) requiring transfusion and one (0.7%) requiring angioembolization; one patient required readmission for observation. Complete STONE clearance was achieved with PCNL alone in 78.2% of the patients. There was a significant correlation of hemoglobin drop with the STONE score, stone size, and preoperative creatinine clearance. Patients with a hemoglobin drop of >1 g/dL had a higher STONE score and mean stone size. The overall complication rate was significantly higher (10.5%) in patients with a hemoglobin drop of >1 g/dL as compared to those with a hemoglobin drop of <1 g/dL (2.8%). Stone complexity as measured by the STONE score correlates with post-PCNL hemoglobin drop, stone clearance, and complication rates. The STONE score may be used for preoperative counseling and to evaluate the potential need for transfusion.

19 August 2020 in Pakistan Journal of Medical Sciences
Verified
Journal Article
Open access
PDF file
MBMuhibullah Bangash
Muhibullah Bangash
WAWajahat Aziz
Wajahat Aziz
Mohammad ShoaibMohammad Shoaib
Mohammad Shoaib
MAM. Hammad Ather
M. Hammad Ather
Objective: To validate an Urdu translation of premature ejaculation diagnostic tool (PEDT) by analyzing the association of this diagnostic tool with the clinical diagnosis of premature ejaculation (PE) and intravaginal ejaculatory latency time (IELT). Methods: This cross-sectional study was conducted at the urology section of the Aga Khan University Hospital, Karachi, for six months duration, from July 2018 to December 2018. In our study 108 subjects, aged 20 to 50 years, who were in a stable sexual relationship (heterosexual) for a minimum duration of six months, were asked to fill the Urdu version of PEDT, 61 with PE and 47 without PE. Results: The two groups matched for mean age, duration of relationship and education level. The duration of 1.2 (±0.5) minutes was the mean self-estimated IELT in the PE group and 3.7±0.9 minutes in patients without PE. There was a significant negative correlation of 0.6 (p-value <0.001) between the PEDT score and self-estimated IELT. The test-retest reliability for each item was found to be significant for each individual item (≥ 0.84, p-value <0.001) and 0.94 was the correlation coefficients of the total score, showing an excellent test-retest reliability. 0.93 was the Cronbach’s alpha score (95% Confidence interval = 0.905 - 0.948) indicating a significant internal consistency in the Urdu version of PEDT. Conclusions: The Urdu version of PEDT is a valid tool to define and quantify PE objectively, with adequate internal consistency. This version of PEDT has a good negative correlation with self-estimated IELT and excellent correlation with clinical PE. doi: https://doi.org/10.12669/pjms.36.6.2405 How to cite this:Bangash M, Aziz W, Shoaib M, Ather MH. Urdu translation and validation of premature ejaculation diagnostic tool (PEDT). Pak J Med Sci. 2020;36(6):1241-1245. doi: https://doi.org/10.12669/pjms.36.6.2405 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Verified
Journal Article
Open access
PDF file
YHYam Ting Ho
Yam Ting Ho
Rizal Rian DhalasRizal Rian Dhalas
Rizal Rian Dhalas
MZMUHAMMAD ZOHAIR
MUHAMMAD ZOHAIR
SDSubrata Deb
Subrata Deb
Mohammad ShoaibMohammad Shoaib
Mohammad Shoaib
Jeremy Yuen Chun TeohJeremy Yuen Chun Teoh
Jeremy Yuen Chun Teoh
Background/Objectives: Artificial intelligence (AI) has been utilised in urological conditions such as urolithiasis, urogynaecology and uro-oncology. The aim of this study is to examine the attitudes and beliefs about AI technology amongst urology healthcare providers. Methods: A structured online questionnaire, created from a modified Delphi method with a panel of urologists and urology surgical trainees, was delivered through the Urological Asia Association’s annual congress. The questionnaire, with 25 items of mixed type responses (five-point Likert scale, nominal-polytomous and open-ended), acquired data regarding demographics, perception and attitudes towards general usage of AI in urological care. Results: A total of 464 respondents from 47 different countries were collected. The results showed that 83.4% of participants believed AI will improve efficiency and 18.8% believed they are knowledgeable in AI technology, with ordinal logistic regression showing both urology specialists and trainees are more likely to agree to these responses. Overall, 51.5% believed AI adoption will not replace clinical practice, and regression analysis found those with previous AI training are more likely to agree to this response. We found AI is commonly used in research, patient education and administrative tasks and identified key enablers as regulatory approval, AI clinical effectiveness and access to AI training. Conclusions: Overall attitudes and beliefs towards the use of AI in urology is positive and encouraging. AI training and education and regulatory reform needs to be addressed to allow integration of AI into clinical practice. A limitation of the study lies in its generalisability to global settings due to the demographics of the respondents.

31 August 2022 in Pakistan Journal of Health Sciences
Verified
Journal Article
Open access
PDF file
IKIsmail Khan
Ismail Khan
MYMalik Aftab Younus
Malik Aftab Younus
Mohammad ShoaibMohammad Shoaib
Mohammad Shoaib
MHMuhammad Haris
Muhammad Haris
NWNoman Ullah Wazir
Noman Ullah Wazir
FDFarah Deeba
Farah Deeba
Benign prostatic hyperplasia is a common health problem affecting men older than 50 years. It is estimated that 30 million men have benign prostatic hyperplasia related clinical features Objective: The objective of this study was to find out the relationship between hypogonadism in patients presenting with benign prostate hyperplasia at tertiary care center. Methods: A descriptive cross-sectional study conducted at Urology Department Lady Reading Hospital Peshawar for a period of one year from June 2019 to May 2020. A total of 361 patients with benign prostate hyperplasia were studied. The sampling technique was consecutive non probability sampling and WHO sample size calculator was used for sample size determination. Serum testosterone level was done all patients as per inclusion criteria. All the data was analyzed in SPSS version 20.0. Results: The mean age, height weight, BMI and testosterone level of qualitative variables were 56.42±10.05, 167.54±9.97, 64.96±12.92, 23.07±4.96 and 15.36±6.36 respectively. The testosterone level decreased with ageing in different age groups. 29.6% patients of our study were 50-59 years old. The hypertensive and diabetic patients with BPH were 31.3% and 22.4% respectively. Out of 361 patients 67 were hypo gonadal men making 18.6%. The hypogonadism had statistically significant mean values of serum testosterone level (p<0.001). Conclusions: This study concluded on the analytical findings that hypogonadism is significantly associated with benign prostate hyperplasia. The testosterone levels decrease with the increase of age and thus patients with low testosterones are more prone to develop benign prostate hyperplasia.

15 February 2021 in Cureus
Verified
Journal Article
Open access
PDF file
Mohammad ShoaibMohammad Shoaib
Mohammad Shoaib
MBMuhibullah Bangash
Muhibullah Bangash
WAWajahat Aziz
Wajahat Aziz
MAM Hammad Ather
M Hammad Ather
Objectives To identify non-invasive predictors of response to tamsulosin 0.4 mg in patients with benign prostatic obstruction (BPO). Methods Males >= 50 years of age with lower urinary tract symptoms (LUTS) suggestive of BPO for over three months were included in the study. We assessed change in the mean International Prostate Symptom Score (IPSS) and maximum flow rate (Qmax) after six weeks of medical therapy. Clinical and uroflowmetry parameters were compared between two groups of patients with >25% vs. <25% change in the IPSS after treatment. Pre- and post-treatment post-void residue (PVR), Qmax, and IPSS were compared by independent t-test, univariate/multivariate regression analysis. Results A total of 121 patients were included. At presentation, the mean prostate size was 35.7 +/- 12.2 grams and the mean IPSS was 16.3 +/- 4.8. Improvement in the mean IPSS was 7.83, with more marked improvement in storage compared to voiding LUTS (5.26 vs. 2.57). Majority (58%) had a quality of life (QoL) score of 4-5 at presentation whereas after 6-weeks of medication (83.5%) had a QoL score of 0-2. Treatment failure was noted in 11 (9.1%) patients. IPSS was higher and Qmax was lower at the time of presentation in patients who had <25% improvement. However, the two groups were identical on the basis of demographic and other factors (BMI, age, prostate size, PVR). Conclusion Moderate LUTS secondary to BPO responds favourably to alpha-blocker (tamsulosin 0.4 mg) treatment. Uroflowmetry (UFM) parameters, that is, Qmax and IPSS are important factors in predicting short-term response to medical therapy.